Scottish Medicines Consortium accepts Ponvory to treat relapsing multiple sclerosis
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the Scottish Medicines Consortium (SMC) has approved Ponvory (ponesimod) for treating adults with relapsing-remitting...